Showing 118 results
March 2023
-
Media Release Achievements and AnnouncementsBreast Cancer
Novartis' Ribociclib Phase III NATALEE trial shows significant benefit for patients with early breast cancer in interim analysis
Ribociclib plus endocrine therapy (ET) significantly reduced the risk of disease recurrence compared to standard ET alone in the adjuvant setting NATALEE is the first and only positive Phase III… -
Media Release Achievements and Announcements
Philippine FDA approves Novartis medicine brolucizumab for the treatment of visual impairment due to diabetic macular edema
The Philippine Food and Drug Administration (FDA) has approved brolucizumab for the treatment of visual impairment due to diabetic macular edema (DME), a common microvascular complication in… -
Media Release Partnerships and Commitments
APPIS 2023: Novartis, patient leaders to hold third annual regional summit to accelerate access, enhance health outcomes
The Alliance and Partnerships for Patient Innovation and Solutions (APPIS) platform will hold its third annual virtual Summit on March 20-21, 2023. Organized by Novartis and co-created by the… -
Media Release Partnerships and Commitments
World Kidney Day: Patient groups partner with Novartis to hold multistakeholder forum on enhancing health access of renal replacement therapy patients
Chronic kidney disease (CKD) is among the leading causes of sickness and death in the Philippines. Latest estimates show that around 2.3 million Filipinos have CKD.3 The National Kidney and…
February 2023
-
Media Release
Novartis broadens access to innovative medicines, leverages data & digital for enhanced cancer care in PH
Novartis continuously finds ways to help improve the quality of care for Filipino patients living with cancer, which is one of the leading causes of illness and death in the Philippines. In… -
Media Release
Novartis associates take on challenge to unblock barriers to better cardiovascular health
To help reduce the heavy burden of cardiovascular diseases (CVDs), Novartis launched the Unblocked movement for heart health – an initiative co-created with external stakeholders in the healthcare… -
Media Release
Novartis: Working with DOH and other partners to end leprosy
Novartis and the Novartis Foundation have been working with the Department of Health and other partners to eliminate leprosy for over 30 years. The Novartis Foundation focuses on influencing…
January 2023
-
Media Release Achievements and AnnouncementsCareers
Novartis Healthcare Philippines recognized as a Top Employer for third consecutive year
Novartis Healthcare Philippines has been officially recognized by the Top Employers Institute as a Top Employer 2023 in the Philippines. To become recognized as a Top Employer, an organization… -
Media Release Partnerships and CommitmentsBreast Cancer
ICanServe, Taguig City, Dashlabs, Novartis launch data-digital project to support breast cancer control program
The ICanServe Foundation, City of Taguig, local healthcare software startup Dashlabs, and Novartis have launched the Circle of Life Data and Digital Infrastructure project to support the Ating…
November 2022
-
Media Release
Novartis partners with DOH, medical societies, hospitals to strengthen healthcare system and improve heart failure management in PH
In a developing country like the Philippines, where healthcare delivery is mostly paid through patients' out-of-pocket expenses, the economic burden of heart failure (HF), especially… -
Media Release
Novartis recognized for supporting eye health services amid pandemic
Novartis Healthcare Philippines was recognized by the National Committee for Sight Preservation (NCSP) for the company’s support to the NCSCP “Maging MATAlino”…